Patents by Inventor Bong Cho Kim

Bong Cho Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
    Patent number: 11970547
    Abstract: The present disclosure relates to a novel anti-HER2 antibody or an antigen-binding fragment thereof used in the prevention or treatment of cancer, a chimeric antigen receptor including the same, and uses thereof. The antibody of the present disclosure is an antibody that specifically binds to HER2 which is highly expressed in cancer cells (particularly, breast cancer or gastric cancer cells), and binds to an epitope that is different from an epitope to which trastuzumab binds.
    Type: Grant
    Filed: April 10, 2023
    Date of Patent: April 30, 2024
    Assignee: GC Cell Corporation
    Inventors: Jong Seo Lee, Kyu Tae Kim, Young Ha Lee, In Sik Hwang, Bong Kook Ko, Eunji Choi, You-Sun Kim, Jeongmin Kim, Miyoung Jung, Hoyong Lim, Sungyoo Cho
  • Composition comprising inhibitor against PAPSS2 gene or protein encoded by gene for inducing senescence in tumor cells and method for inducing senescence in tumor cells using the same
    Patent number: 9550995
    Abstract: Provided is a composition for inducing tumor cell senescence and a method for inducing tumor cell senescence using the same. The composition can inhibit a PAPSS2 gene in a tumor cell to thereby induce senescence of the tumor cell, and if the composition is used concurrently with irradiation of the tumor cell, the composition can improve the sensitivity of the tumor cell to radiation.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: January 24, 2017
    Assignees: Korea Institute of Radiological & Medical Sciences, Inha University Research and Business Foundation
    Inventors: Jae-Seon Lee, Seung Hee Jung, Bong Cho Kim, Hyung Chul Lee, Na-Kyung Han, Mi-Na Hong
  • COMPOSITION COMPRISING INHIBITOR AGAINST PAPSS2 GENE OR PROTEIN ENCODED BY GENE FOR INDUCING SENESCENCE IN TUMOR CELLS AND METHOD FOR INDUCING SENESCENCE IN TUMOR CELLS USING THE SAME
    Publication number: 20160060633
    Abstract: Provided is a composition for inducing tumor cell senescence and a method for inducing tumor cell senescence using the same. The composition can inhibit a PAPSS2 gene in a tumor cell to thereby induce senescence of the tumor cell, and if the composition is used concurrently with irradiation of the tumor cell, the composition can improve the sensitivity of the tumor cell to radiation.
    Type: Application
    Filed: May 20, 2013
    Publication date: March 3, 2016
    Inventors: Jae-Sun LEE, Seung Hee JUNG, Bong Cho KIM, Hyung Chul LEE, Na-Kyung HAN, Mi-Na HONG
  • Anticancer composition
    Patent number: 8809297
    Abstract: Disclosed is an anticancer composition, comprising an inhibitor against WIG1 and/or YPEL5 or against a protein encoded by the gene. A composition for screening an anticancer agent comprising a nucleic acid having a sequence complementary to an mRNA of WIG1 and/or YPEL5, or an antibody to a protein encoded by the gene is also provided. Also, a method is provided for screening an anticancer agent, which comprises: (A) quantitatively analyzing expression of WIG1 and/or YPEL5 at an mRNA or protein level in a tumor cell which is not treated with a candidate for an anticancer agent; (B) quantitatively analyzing expression of the gene at an mRNA or protein level in a tumor cell after treatment of the candidate for an anticancer agent; and (C) selecting the candidate if the expression level of the gene is increased in step (B), compared to step (A).
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: August 19, 2014
    Assignee: Korea Institute of Radiological & Medical Sciences
    Inventors: Jae-Seon Lee, Bong Cho Kim, Je-Jung Lee, Su Min Park
  • ANTICANCER COMPOSITION
    Publication number: 20130149319
    Abstract: Disclosed is an anticancer composition, comprising an inhibitor against WIG1 and/or YPEL5 or against a protein encoded by the gene. A composition for screening an anticancer agent comprising a nucleic acid having a sequence complementary to an mRNA of WIG1 and/or YPEL5, or an antibody to a protein encoded by the gene is also provided. Also, a method is provided for screening an anticancer agent, which comprises: (A) quantitatively analyzing expression of WIG1 and/or YPEL5 at an mRNA or protein level in a tumor cell which is not treated with a candidate for an anticancer agent; (B) quantitatively analyzing expression of the gene at an mRNA or protein level in a tumor cell after treatment of the candidate for an anticancer agent; and (C) selecting the candidate if the expression level of the gene is increased in step (B), compared to step (A).
    Type: Application
    Filed: May 28, 2010
    Publication date: June 13, 2013
    Applicant: KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
    Inventors: Jae-Seon Lee, Bong Cho Kim, Je-Jung Lee, Su Min Park